Health care of Kyrgyzstan
Zdravoohraneniye Kyrgyzstana

ISSN 1694-8068 (Print)

ISSN 1694-805X (Online)

Log in

Vulvar cancer statistics in two Central Asian republics (Kazakhstan and Kyrgyzstan)

https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
Vulvar cancer statistics in two Central Asian republics (Kazakhstan and Kyrgyzstan)
Полный текст Full text  

PDF (RUS)

PDF (RUS)
Abstract About the authors References

Abstract

Introduction. Vulvar cancer is a rare malignant neoplasm of the external genital organs. It most commonly occurs in elderly women. Objective of the study. To conduct a comparative analysis of certain epidemiological aspects of vulvar cancer in two neighboring Central Asian republics — Kazakhstan and Kyrgyzstan. Materials and methods. The study covers the period from 2003 to 2012 and includes women with newly diagnosed cases of vulvar cancer in both countries. The material for the study comprised all registered cases of vulvar cancer from official sources. Results and discussion. A total of 852 cases of vulvar cancer were registered in the Republic of Kazakhstan and 92 in the Kyrgyz Republic. The average annual crude incidence rate of vulvar cancer was 1.1 per 100,000 in Kazakhstan and 0.3 in Kyrgyzstan. The age-standardized incidence rate was 0.9 and 0.3, respectively. Incidence was statistically significantly higher among Russian women compared to the indigenous ethnic groups. Conclusion. There is notable geographical and ethnic variability in vulvar cancer incidence between the two countries, with a slightly higher rate observed in the Republic of Kazakhstan compared to the Kyrgyz Republic. The descriptive epidemiological data obtained are of practical importance for understanding the etiology of the disease.

About the authors

Айтышова Динара Кубатбековна, врач радиогинеколог, отд. радиогинекологии, Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика

Макимбетов Эмил Кожошович, доктор медицинских наук, зав. каф. онкологии Кыргызско-Российского Славянского Университета имени первого Президента Российской Федерации Б.Н. Ельцина, Бишкек, Кыргызская Республика

Aityshova Dinara Kubatbekovna, radiogynecologist, dept. Radiogynecology, National Center of Oncology and Hematology, Bishkek, Kyrgyz Republic

Makimbetov Emil Kozhoshovich, Doctor of Medical Sciences, Head of the Department of Oncology, Kyrgyz-Russian Slavic University named after the first President of the Russian Federation B.N. Yeltsin, Bishkek, Kyrgyz Republic

Айтышова Динара Кубатбековна, Улуттук онкология жана гематология борборунун радиогинекология бөлүмүнүн радиогинекологу, Бишкек, Кыргыз Республикасы

Макимбетов Эмил Кожошович, медицина илимдеринин доктору, Россия Федерациясынын биринчи президенти Б.Н. атындагы Кыргыз-Орус Славян университетинин онкология кафедрасынын башчысы. Ельцин, Бишкек, Кыргыз Республикасы

References

1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.

1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.

1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.

Keywords
Vulvar cancer , Statistics , Incidence , Indicator , Variability
Для цитирования

Айтышова Д.К., Макимбетов Э.К. Статистика рака вульвы в двух республиках Центральной Азии (Казахстан и Кыргызстан). Научно-практический журнал «Здравоохранение Кыргызстана» 2025, № 3, с. 47-50. https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
For citation

Aityshova D.K., Makimbetov E.K.Vulvar cancer statistics in two Central Asian republics (Kazakhstan and Kyrgyzstan). Scientific practical journal “Health care of Kyrgyzstan”2025, No.3, p. 47-50. https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
Цитата үчүн

Айтышова Д.К., Макимбетов Э.К. Вульва рагы боюнча статистика Борбор Азиянын эки республикасында (Казакстан жана Кыргызстан). Кыргызстандын саламаттык сактоо илимий-практикалык журналы 2025, № 3, б. 47-50. https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
Authors Aityshova D.K., Makimbetov E.K.
Link doi.org https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
Pages 47-50
Keywords Vulvar cancer, Statistics, Incidence, Indicator, Variability
Russian
Об авторах

Айтышова Динара Кубатбековна, врач радиогинеколог, отд. радиогинекологии, Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика

Макимбетов Эмил Кожошович, доктор медицинских наук, зав. каф. онкологии Кыргызско-Российского Славянского Университета имени первого Президента Российской Федерации Б.Н. Ельцина, Бишкек, Кыргызская Республика
Полный текст

PDF (RUS)
Список литературы

1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.

Для цитирования

Айтышова Д.К., Макимбетов Э.К. Статистика рака вульвы в двух республиках Центральной Азии (Казахстан и Кыргызстан). Научно-практический журнал «Здравоохранение Кыргызстана» 2025, № 3, с. 47-50. https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
English
About authors

Aityshova Dinara Kubatbekovna, radiogynecologist, dept. Radiogynecology, National Center of Oncology and Hematology, Bishkek, Kyrgyz Republic

Makimbetov Emil Kozhoshovich, Doctor of Medical Sciences, Head of the Department of Oncology, Kyrgyz-Russian Slavic University named after the first President of the Russian Federation B.N. Yeltsin, Bishkek, Kyrgyz Republic
Full text

PDF (RUS)
References

1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.

For citation

Aityshova D.K., Makimbetov E.K.Vulvar cancer statistics in two Central Asian republics (Kazakhstan and Kyrgyzstan). Scientific practical journal “Health care of Kyrgyzstan”2025, No.3, p. 47-50. https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
Kyrgyz
Авторлор жөнүндө

Айтышова Динара Кубатбековна, Улуттук онкология жана гематология борборунун радиогинекология бөлүмүнүн радиогинекологу, Бишкек, Кыргыз Республикасы

Макимбетов Эмил Кожошович, медицина илимдеринин доктору, Россия Федерациясынын биринчи президенти Б.Н. атындагы Кыргыз-Орус Славян университетинин онкология кафедрасынын башчысы. Ельцин, Бишкек, Кыргыз Республикасы
Шилтемелер

1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.

Цитата үчүн

Айтышова Д.К., Макимбетов Э.К. Вульва рагы боюнча статистика Борбор Азиянын эки республикасында (Казакстан жана Кыргызстан). Кыргызстандын саламаттык сактоо илимий-практикалык журналы 2025, № 3, б. 47-50. https://dx.doi.org/10.51350/zdravkg2025.3.9.5.47.50
Views: 122
Copyright MAXXmarketing GmbH
JoomShopping Download & Support